Results 301 to 310 of about 65,650,609 (376)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham+21 more
wiley +1 more source
From chaos to symbiosis: exploring adaptive co-evolution strategies for generative AI and research integrity systems. [PDF]
Miao W+12 more
europepmc +1 more source
A conversation with Keith McCrae, MD, staff and professor of molecular medicine, Cleveland Clinic
Clinical Research Forum
doaj +1 more source
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban+12 more
wiley +1 more source
Population data on Finland 1900-1983
Population Research Institute
doaj
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik+4 more
wiley +1 more source
Historical Nonsuicidal Self-Injury and Current Coping Strategies: The Role of Emotion Regulation. [PDF]
Bradley H, Orchard F, Matcham F.
europepmc +1 more source